New York City COVID-19 resident physician exposure during exponential phase of pandemic.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 27 04 2020
accepted: 21 05 2020
pubmed: 29 5 2020
medline: 12 9 2020
entrez: 29 5 2020
Statut: ppublish

Résumé

BACKGROUNDFrom March 2, 2020, to April 12, 2020, New York City (NYC) experienced exponential growth of the COVID-19 pandemic due to novel coronavirus (SARS-CoV-2). Little is known regarding how physicians have been affected. We aimed to characterize the COVID-19 impact on NYC resident physicians.METHODSIRB-exempt and expedited cross-sectional analysis through survey to NYC residency program directors April 3-12, 2020, encompassing events from March 2, 2020, to April 12, 2020.RESULTSFrom an estimated 340 residency programs around NYC, recruitment yielded 91 responses, representing 24 specialties and 2306 residents. In 45.1% of programs, at least 1 resident with confirmed COVID-19 was reported. One hundred one resident physicians were confirmed COVID-19-positive, with an additional 163 residents presumed positive for COVID-19 based on symptoms but awaiting or unable to obtain testing. Two COVID-19-positive residents were hospitalized, with 1 in intensive care. Among specialties with more than 100 residents represented, negative binomial regression indicated that infection risk differed by specialty (P = 0.039). In 80% of programs, quarantining a resident was reported. Ninety of 91 programs reported reuse or extended mask use, and 43 programs reported that personal protective equipment (PPE) was suboptimal. Sixty-five programs (74.7%) redeployed residents elsewhere to support COVID-19 efforts.CONCLUSIONMany resident physicians around NYC have been affected by COVID-19 through direct infection, quarantine, or redeployment. Lack of access to testing and concern regarding suboptimal PPE are common among residency programs. Infection risk may differ by specialty.FUNDINGNational Eye Institute Core Grant P30EY019007; Research to Prevent Blindness Unrestricted Grant; Parker Family Chair; University of Pennsylvania.

Identifiants

pubmed: 32463802
pii: 139587
doi: 10.1172/JCI139587
pmc: PMC7456242
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4726-4733

Subventions

Organisme : NEI NIH HHS
ID : P30 EY019007
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Int J Infect Dis. 2020 Apr;93:264-267
pubmed: 32114193
Urology. 2020 Jun;140:1-3
pubmed: 32247725
N Engl J Med. 2020 May 14;382(20):1957-1958
pubmed: 32243118
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
JAMA. 2020 Mar 11;:
pubmed: 32159775
Biosci Trends. 2020 Mar 16;14(1):3-8
pubmed: 32062645
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Eye Vis (Lond). 2020 Apr 7;7:19
pubmed: 32289038
J Am Acad Dermatol. 2020 Jun;82(6):1572-1573
pubmed: 32259536
JAMA Ophthalmol. 2020 Mar 31;:
pubmed: 32232433
PLoS One. 2010 Jul 26;5(7):e11655
pubmed: 20668679

Auteurs

Mark P Breazzano (MP)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.
Department of Ophthalmology, New York University School of Medicine, New York University Langone Health, New York, New York, USA.
Manhattan Eye, Ear and Throat Hospital, Lenox Hill Hospital, Northwell Health, New York, New York, USA.

Junchao Shen (J)

Department of Neurology and.

Aliaa H Abdelhakim (AH)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.
Department of Ophthalmology, New York University School of Medicine, New York University Langone Health, New York, New York, USA.
Manhattan Eye, Ear and Throat Hospital, Lenox Hill Hospital, Northwell Health, New York, New York, USA.

Lora R Dagi Glass (LRD)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.

Jason D Horowitz (JD)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.

Sharon X Xie (SX)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

C Gustavo de Moraes (CG)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.

Alice Chen-Plotkin (A)

Department of Neurology and.

Royce Ws Chen (RW)

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH